Brainsway Raises $8.5 Million From Leading Israeli Investors
12 déc. 2017 16h01 HE
|
Brainsway Ltd.
Phoenix Group becomes 7% shareholder Financing strengthens Brainsway's balance sheet and provides strong support for continued growth HACKENSACK, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) --...
Brainsway Reports Record Quarterly Revenues in Third Quarter of 2017
20 nov. 2017 09h42 HE
|
Brainsway Ltd.
Increased market demand and new leasing model continue to generate significant sales growth Recently signed contracts increased total minimum revenue projection by 21% over end of second quarter to...
Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017
22 août 2017 08h00 HE
|
Brainsway Ltd.
Backlog revenues due to future lease agreements increased 27% to $19 million Quarterly revenues increased 11% Brainsway reports a receipt of a bank credit line for $6 million for a period of 42...
Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression
22 juin 2017 17h12 HE
|
Brainsway Ltd.
HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today...
Brainsway® Announces Positive Final Results of its Deep TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients
12 juin 2017 12h35 HE
|
Brainsway Ltd.
Brainsway will prepare a submission to the FDA to market the device for OCD Deep TMS treatment led to statistically significant and meaningful improvements in patients suffering from OCD Patients...
CORRECTING and REPLACING – Brainsway Reports Strong Momentum in Q1 for 2017
08 juin 2017 17h09 HE
|
Brainsway Ltd.
HACKENSACK, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline on June 6th by Brainsway Ltd. (TASE:BRIN), please note in the fifth paragraph, the third...
Brainsway Reports Strong Momentum in Q1 for 2017
06 juin 2017 13h20 HE
|
Brainsway Ltd.
HACKENSACK, N.J., June 06, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...
Brainsway Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth
05 avr. 2017 09h01 HE
|
Brainsway Ltd.
HACKENSACK, N.J., April 05, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...
Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry
03 avr. 2017 12h02 HE
|
Brainsway Ltd.
JERUSALEM, April 03, 2017 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), the leader in the development of advanced noninvasive treatments for brain disorders, announced today the start of Yaacov...
Brainsway Appoints Yaacov Michlin as CEO
10 janv. 2017 09h00 HE
|
Brainsway Ltd.
JERUSALEM, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), the leader in the development of advanced noninvasive treatments for brain disorders, announced today the appointment of...